ArticleCureus2025
When Two Roads Intersect: Coexisting Achalasia Cardia and Oesophageal Varices as a Therapeutic Dilemma.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Achalasia is a rare cause of oesophageal dysmotility. This disorder causes impaired relaxation of the lower oesophageal sphincter (LOS), impacting peristalsis and the normal movement of food through the digestive tract, resulting in worsening swallowing difficulty, known as dysphagia. Although various effective treatments are available, like pneumatic dilation, laparoscopic Heller myotomy, and peroral endoscopic myotomy (POEM), patients with portal hypertension may develop oesophageal varices, which complicates treatment due to the heightened risk of severe bleeding. We present the case of a 45-year-old man with a history of cirrhosis and chronic hepatitis C who developed progressively worsening dysphagia over four months, which led to significant weight loss over this period and prompted further investigation. An oesophagogastroduodenoscopy (OGD) showed a dilated oesophagus with retained food contents and grade II oesophageal varices without any endoscopic red signs. Additionally, a barium swallow and high-resolution manometry were done, which led to the confirmation of the diagnosis of achalasia cardia. Given the high risk of bleeding associated with conventional therapies in the presence of varices, a safer, minimally invasive approach was chosen. Botulinum toxin was carefully injected into the LOS under endoscopic ultrasound (EUS) guidance to avoid the variceal sites and negate the risk of bleeding. This approach allowed targeted treatment of achalasia while minimising the risk of variceal bleeding. The patient experienced significant improvement in dysphagia without complications. This case highlights the rare and challenging coexistence of achalasia and oesophageal varices. It highlights the need for considering individualised treatment strategies in high-risk individuals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.